TARGET PRODUCT PROFILES FOR ANTIBACTERIAL RESISTANCE DIAGNOSTICS
The WHO Target Product Profiles (TPP) document informs product developers, regulatory agencies, procurement agencies and funders on R&D and public health priorities. It is intended to facilitate the most expeditious development of products addressing the greatest and most urgent public health needs. The development of WHO TPPs follows a standardized procedure and includes a number of steps. These include (i) doing a needs assessment; (ii) constituting a scientific TPP development group (with standard WHO Declaration of Interest procedures); (iii) drafting and sharing an initial draft of the TPP with the development group; (iv) revising, posting and disseminating a new version of the TPP for public consultation for 28 days (with comment form); (v) revising and finalizing the TPP (an additional consultation step may be needed in case of significant disagreement); and (vi) posting and disseminating the final version of the TPP.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.